Concepedia

Qingyu Luo

QL

17

Publications

709

Citations

16

H-Index

2018

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Harvard University

Dana-Farber Cancer Institute

Zhejiang Cancer Hospital

Beijing Proteome Research Center

Qingyu Luo is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2018–2024

17

Publications

17

OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation

Qingyu Luo, Xiaowei Wu, Pengfei Zhao et al. · Advanced Science · 2021 · 109 citations · Full text

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Proceedings of the National Academy of Sciences · 2019 · 90 citations · Full text

JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Cell Death and Differentiation · 2019 · 81 citations · Full text

, , +10

ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2

Qingyu Luo, Xiaowei Wu, Yiping Zhang et al. · Cancer Letters · 2018 · 57 citations

, , +10

TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma

Qingyu Luo, Xiaowei Wu, Yabing Nan et al. · Cell Reports · 2020 · 53 citations · Full text

Rows per page

1–5 of 17